JOSÉ ÁNGEL
GARCÍA SÁENZ
Profesor asociado de Ciencias de la Salud
EVA MARÍA
CIRUELOS GIL
Profesora asociada de Ciencias de la Salud
Publicaciones en las que colabora con EVA MARÍA CIRUELOS GIL (8)
2024
-
Safety profile of trastuzumab deruxtecan in advanced breast cancer: Expert opinion on adverse event management
Clinical and Translational Oncology
2022
-
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer
Annals of Oncology, Vol. 33, Núm. 12, pp. 1250-1268
2021
-
Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication
Annals of Oncology, Vol. 32, Núm. 10, pp. 1245-1255
-
Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant metastatic breast cancer: a phase III randomised controlled trial—PEARL
Annals of Oncology, Vol. 32, Núm. 4, pp. 488-499
2020
-
Abemaciclib, a CDK4 and CDK6 inhibitor for the treatment of metastatic breast cancer
Future Oncology, Vol. 16, Núm. 33, pp. 2763-2778
2019
-
SEOM clinical guidelines in early stage breast cancer (2018)
Clinical and Translational Oncology, Vol. 21, Núm. 1, pp. 18-30
2015
-
SEOM clinical guidelines in early-stage breast cancer 2015
Clinical and Translational Oncology, Vol. 17, Núm. 12, pp. 939-945
2014
-
Lapatinib plus trastuzumab in pretreated human epidermal growth factor receptor 2-positive metastatic breast cancer
Journal of Cancer Research and Therapeutics, Vol. 10, Núm. 4, pp. 967-972